The obesity market is rapidly transforming as new therapies, evolving care models, and changing patient behaviors create demand for a new evidence approach. Once viewed primarily as a lifestyle condition, obesity is now recognized as a chronic disease with complex clinical, economic, and societal impacts. Traditional data sources often fail to capture patient diversity, treatment pathways, and real-world decisions, especially as medical, digital health, and self-pay care models expand. Effective obesity strategies require purpose-built evidence that reflects differences in biology, comorbidities, treatment goals, access, and long-term outcomes. By integrating richer real-world data and patient insights, organizations can better understand the market, support decision-making, and improve ca

Join for free to read